08:15 – 10:05 am

SESSION 1: MOBILE NEURODIAGNOSTICS FOR STROKE DETECTION AND MANAGEMENT

Chair: Jim Grotta, Clinical Institute for Research and Innovation at Memorial Hermann – Texas Medical Center, Houston, TX

08:15 – 08:35
PREHOSPITAL AND ICU PARADIGMS FOR STROKE DIAGNOSES
08:15 – 08:25 Presentation by Nerses Sanossian, University of Southern California, Los Angeles, CA
08:25 – 08:35 Comments by TBA

08:35 – 08:55
MOBILE USE OF STANDARD IMAGING: PREHOSPITAL CT IMAGING
08:35 – 08:45 Presentation by TBA
08:45 – 08:55 Comments by Andrei Alexandrov, University of Arizona College of Medicine, Phoenix, AZ

08:55 – 09:15 
MOBILE USE OF STANDARD IMAGING: MRI IMAGING IN THE ICU
08:55 – 09:05 Presentation by TBA
09:05 – 09:15 Comments by TBA

09:15-10:05  ROUNDTABLE PANEL DISCUSSION

Nerses Sanossian, University of Southern California, Los Angeles, CA,
TBC

10:25 – 12:15 pm

SESSION 2: ACUTE ISCHEMIC STROKE CHARACTERIZATION AND QUANTIFICATION

Chair: Steven Warach, University of Texas

10:25 – 10:45
TO QUANTIFY OR NOT TO QUANTIFY: DOES SIZE MATTER?
10:25 – 10:35 Presentation by TBA
10:35 – 10:45 Comments by Raul Nogueira, University of Pittsburgh School of Medicine,  PA

10:45 – 11:05
STROKE CHARACTERIZATION AND QUANTIFICATION: CT APPROACH
10:45 – 10:55 Presentation by Lily Wang, University of Cincinnati College of Medicine, OH
10:55 – 11:05 Comments by Maarten Lansberg, Stanford University, Stanford, CA

11:05 – 11:25
STROKE CHARACTERIZATION AND QUANTIFICATION: MRI APPROACH
11:05 – 11:15 Presentation by Kambiz Nael, The University of California, San Francisco, CA
11:15 – 11:25 Comments by Ona Wu, Massachusetts General Hospital and Harvard Medical School, Boston, MA

11:25 – 12:15 ROUNDTABLE PANEL DISCUSSION

Maarten Lansberg, Stanford University, Stanford, CA,
Kambiz Nael, The University of California, San Francisco, CA,
Lily Wang, University of Cincinnati College of Medicine, OH,
Steven Warach, The University of Texas at Austin, TX,
TBC

1:15 – 3:05 pm

SESSION 3: NEUROIMAGING EVALUATION IN THERAPEUTIC DRUG/DEVICE DEVELOPMENT 

1:15 – 1:35
WHICH ONE MATTERS MOST: THERAPEUTIC RESPONSE OR CLINICAL OUTCOME
1:15 – 1:25 Presentation by Pooja Khatri, University of Cincinnati College of Medicine, OH
1:25 – 1:35 Comments by Opeolu Adeoye, Washington University School of Medicine in St. Louis, MO

1:35 – 1:55
USE OF AUTOMATED AND STANDARD IMAGING INTERPRETATION TO PREDICT THERAPEUTIC RESPONSE
1:35 – 1:45 Presentation by TBA
1:45 – 1:55 Comments by Jason Allen, Indiana University School of Medicine, Indianapolis, IN

1:55 – 2:15
IMAGING CORE LAB METHODOLOGY AND FUNCTIONS FOR CLINICAL TRIALS
1:55 – 2:05 Presentation by David Liebeskind, University of California, Los Angeles, CA
2:05 – 2:15 Comments by Achala Vagal, University of Cincinnati College of Medicine, OH

2:15 – 3:05  ROUNDTABLE PANEL DISCUSSION

Colin Derdeyn, The University of Virginia School of Medicine, Charlottesville,VA
Pooja Khatri, University of Cincinnati College of Medicine, OH
David Liebeskind, University of California, Los Angeles, CA
TBC

3:25 – 5:15 pm

SESSION 4: NEUROIMAGING FOR HEMORRHAGE DETECTION

Chair: Achala Vagal, University of Cincinnati College of Medicine, OH

3:25 – 3:45
DEFINITIONS OF HEMORRHAGIC TRANSFORMATION: WHAT MATTERS?
3:25 – 3:35 Presentation by Jens Fiehler, University Medical Center Hamburg-Eppendorf, Germany
3:35 – 3:45 Comments by Arindam Chatterjee, Stanford University School of Medicine, Stanford, CA

3:45 – 4:05
IMAGING OF HEMORRHAGIC TRANSFORMATION: IMPLICATIONS FOR CLINICAL PRACTICE
3:45 – 3:55 Presentation by Vivek Yedavalli, Johns Hopkins Medicine, Baltimore, MD
3:55 – 4:05 Comments by Joseph Broderick, University of Cincinnati College of Medicine, OH

4:05 – 4:25
BALANCING SAFETY: THE ROLE OF DEVICES AND DRUGS IN HEMORRHAGIC TRANSFORMATION
4:05 – 4:15 Presentation by David Liebeskind, University of California, Los Angeles, CA
4:15 – 4:25 Comments by TBA

4:25 – 5:15 ROUNDTABLE PANEL DISCUSSION

Jens Fiehler, University Medical Center Hamburg-Eppendorf, Germany,
Achala Vagal, University of Cincinnati College of Medicine, OH,
Vivek Yedavalli, Johns Hopkins Medicine, Baltimore, MD,
David Liebeskind, University of California, Los Angeles, CA,
TBC